본문 바로가기
KERD
논문KCI 등재

Therapeutic Potential of Lactiplantibacillus plantarum FB091 in Alleviating Alcohol-Induced Liver Disease through Gut-Liver Axis

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류생물학

초록

Alcoholic liver disease (ALD) poses a significant global health burden, often requiring liver transplantation and resulting in fatalities. Current treatments, like corticosteroids, effectively reduce inflammation but carry significant immunosuppressive risks. This study evaluates Lactiplantibacillus plantarum FB091, a newly isolated probiotic strain, as a safer alternative for ALD treatment. Using an in vivo mouse model, we assessed the effects of L. plantarum FB091 on alcoholinduced liver damage and gut microbiota composition. Alcohol and probiotics administration did not significantly impact water/feed intake or body weight. Histopathological analysis showed that L. plantarum FB091 reduced hepatocellular ballooning and inflammatory cell infiltration in liver tissues and mitigated structural damage in colon tissues, demonstrating protective effects against alcohol-induced damage. Biomarker analysis indicated that L. plantarum FB091 decreased aspartate aminotransferase levels, suggesting reduced liver damage, and increased alcohol dehydrogenase activity, indicating enhanced alcohol metabolism. Additionally, cytokine assays revealed a reduction in pro-inflammatory TNF-α and an increase in anti-inflammatory IL-10 levels in colon tissues of the L. plantarum FB091 group, suggesting an anti- inflammatory effect. Gut microbiota analysis showed changes in the L. plantarum FB091 group, including a reduction in Cyanobacteria and an increase in beneficial bacteria such as Akkermansia and Lactobacillus. These changes correlated with the recovery and protection of liver and colon health. Overall, L. plantarum FB091 shows potential as a therapeutic probiotic for managing ALD through its protective effects on liver and colon tissues, enhancement of alcohol metabolism, and beneficial modulation of gut microbiota. Further clinical studies are warranted to confirm these findings in humans.

Abstract

Alcoholic liver disease (ALD) poses a significant global health burden, often requiring liver transplantation and resulting in fatalities. Current treatments, like corticosteroids, effectively reduce inflammation but carry significant immunosuppressive risks. This study evaluates Lactiplantibacillus plantarum FB091, a newly isolated probiotic strain, as a safer alternative for ALD treatment. Using an in vivo mouse model, we assessed the effects of L. plantarum FB091 on alcoholinduced liver damage and gut microbiota composition. Alcohol and probiotics administration did not significantly impact water/feed intake or body weight. Histopathological analysis showed that L. plantarum FB091 reduced hepatocellular ballooning and inflammatory cell infiltration in liver tissues and mitigated structural damage in colon tissues, demonstrating protective effects against alcohol-induced damage. Biomarker analysis indicated that L. plantarum FB091 decreased aspartate aminotransferase levels, suggesting reduced liver damage, and increased alcohol dehydrogenase activity, indicating enhanced alcohol metabolism. Additionally, cytokine assays revealed a reduction in pro-inflammatory TNF-α and an increase in anti-inflammatory IL-10 levels in colon tissues of the L. plantarum FB091 group, suggesting an anti- inflammatory effect. Gut microbiota analysis showed changes in the L. plantarum FB091 group, including a reduction in Cyanobacteria and an increase in beneficial bacteria such as Akkermansia and Lactobacillus. These changes correlated with the recovery and protection of liver and colon health. Overall, L. plantarum FB091 shows potential as a therapeutic probiotic for managing ALD through its protective effects on liver and colon tissues, enhancement of alcohol metabolism, and beneficial modulation of gut microbiota. Further clinical studies are warranted to confirm these findings in humans.

참고문헌 (55)

  1. Morojele NK, "Alcohol use and the risk of communicable diseases", Nutrients, 13, pp.3317~ (2021)
  2. Im PK, "Alcohol consumption and risks of more than 200 diseases in Chinese men", Nat. Med, 29, pp.1476~1486 (2023)
  3. Millwood IY, "Alcohol intake and cause-specific mortality: conventional and genetic evidence in a prospective cohort study of 512,000 adults in China", Public Health, 12, pp.E956~E957 (2023)
  4. Parry C, "Alcohol consumption and non-conmmunicable diseases : epidemiology and policy implications", Addiction, 106, pp.1718~1724 (2012)
  5. Maher JJ, "Exploring alcohol’s effects on liver function", Alcohol Health Res. World, 21, pp.5~12 (1997)
  6. Osna NA, "Alcoholic liver disease : pathogenesis and current management", Alcohol Res, 38, pp.147~161 (2017)
  7. Cholankeril G, "Alcoholic liver disease replaces hepatitis C virus infection and the leading indication for liver transplantation in the United States", Clin. Gastroenterol. Hepatol, 16, pp.1356~1358 (2018)
  8. Pimpin L, "Burden of liver disease in Europe : epidemiology and analysis of risk factors to identify prevention policies", J. Hepatol, 69, pp.718~735 (2018)
  9. Maddur H, "Current therapies for alcohol-associated hepatitis", Clin. Liver Dis, 25, pp.595~602 (2021)
  10. Louvet A, , Hepatology, 45, pp.1348~1354 (2007)
  11. Chaudhry H, "Alcohol-related hepatitis : a review article", World J. Gastroenterol, 29, pp.2551~2570 (2023)
  12. Louvet A, "Infection in patients with severe alcoholic hepatitis treated with steroids : early response to therapy is the key factor", Gastroenterology, 137, pp.541~548 (2009)
  13. Asai N, "Corticosteroids treatment alters lung and gut microbiome communities that correlates to increased pathologic immune response", J. Immunol, 208, pp.50.08~50.08 (2022)
  14. Zhang J, "Integrative analysis of gut microbiota and fecal metabolites in rats after prednisone treatment", Microbiol. Spectr, 9, pp.e00650-21~ (2021)
  15. Dixon WG, "Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis : a nested case-control analysis", Ann. Rheum. Dis, 71, pp.1128~1233 (2012)
  16. Hill C, "The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic", Nat. Rev. Gastroenterol. Hepatol, 11, pp.506~514 (2014)
  17. Hemarajata P, "Effects of probiotics on gut microbiota : mechanisms of intestinal immunomodulation and neuromodulation", Therap. Adv. Gastroenterol, 6, pp.39~51 (2013)
  18. Maftei NM, "The potential impact of probiotics on human health : an update on their health-promoting properties", Microorganisms, 12, pp.234~ (2024)
  19. Zheng Z, "The gut-liver axis in health and disease : the role of gut microbiota-derived signals in liver injury and regeneration", Front. Immunol, 12, pp.7755226~ (2021)
  20. Hong M, "Probiotics(Lactobacillus rhamnosus R0011 and acidophilus R0052)reduce the expression of toll-like receptor 4 in mice with alcoholic liver disease", PLoS One, 10, pp.e9117451~ (2015)
  21. Tian F, "Lactobacillus rhamnosus CCFM1107 treatment ameliorates alcoholinduced liver injury in a mouse model of chronic alcohol feeding", J. Microbiol, 53, pp.856~863 (2015)
  22. Xiong SY, "Clinical efficacy of probiotics in the treatment of alcoholic liver disease : a systematic review and meta-analysis", Front. Cell. Infect. Microbiol, 14, pp.1358063~ (2024)
  23. Li H, "Lactobacillus plantarum KLDS1.0344 and Lactobacillus acidophilus KLDS1.0901mixture prevents chronic alcoholic liver injury in mice by protecting the intestinal barrier and regulating gut microbiota and liverrelated pathways", J. Agric. Food Chem, 69, pp.183~197 (2021)
  24. Kim WG, "Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 mitigate alcoholic steatosis in mice by inhibiting LPS-mediated NF-kB activation through restoration of the distributed gut microbiota", Food Funct, 9, pp.4255~4265 (2018)
  25. Huang H, "Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model", Exp. Ther. Med, 16, pp.4733~4739 (2019)
  26. Chayanupatkul M, "Probiotics and their beneficial effects on alcohol-induced liver injury in a rat model : the role of fecal microbiota", BC Complement. Med. Ther, 22, pp.168~ (2022)
  27. Wang Y, "Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury", J. Nutr. Biochem, 24, pp.1609~1615 (2013)
  28. Bull-Otterson L, "Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment", PLoS One, 8, pp.e53028~ (2013)
  29. Wick RR, "Performance of neural network basecalling tools for Oxford Nanopore sequencing", Genome Biol, 20, pp.129~ (2019)
  30. "qcat: a tool for demultiplexing nanopore reads" (2019)[URL]
  31. Curry KD, "Emu : species-level microbial community profiling for full-length nanopore 16S reads", Nat. Methods, 19, pp.845~583 (2022)
  32. Stoddard SF, "rrnDB : improved tools for interpreting rRNA gene abundance in bacteria and archaea and a new foundation for future development", Nucleic Acids Res, 43, pp.D593~D598 (2015)
  33. O’Leary NA, "Reference sequence(RefSeq)database at NCBI : current status, taxonomic expansion, and functional annotation", Nucleic Acids Res, 44, pp.D733~D745 (2016)
  34. Li H, "Minimap2 : pairwias alignment for nucleotide sequences", Bioinformatics, 34, pp.3094~3100 (2018)
  35. Wickham H, "ggplot2: Elegant graphics for data analysis" (2016), Springer-Verlag
  36. Hernandez BY, "Oral Cyanobacteria and hepatocellular carcinoma", Cancer Epidemiol. Biomarkers Prev, 31, pp.221~229 (2022)
  37. Li T, "Advances in investigating microcystin-induced liver toxicity and underlying mechanisms", Sci. Total Environ, 905, pp.167167~ (2023)
  38. Soo RM, "Back from the dead; the curious tale of the predatory cyanobacterium Vampirovibrio chlorellavorus", PeerJ, 3, pp.e968~ (2015)
  39. Caballero JD, "Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period", mBio, 8, pp.10.1128~ (2017)
  40. Shen M, "Alcohol-induced gut microbiome dysbiosis enhances the colonization of Klebsiella pneumoniae on the mouse intestinal tract", mSyetems, 9, pp.e00052-24~ (2024)
  41. Cho YE, "Fructose promotes leaky gut, endotoxemia, and liver fibrosis through ethanol-inducible cytochrome P450-2E1-Mediated oxidative and nitrative stress", Hepatology, 73, pp.2180~2195 (2021)
  42. Zhong X, "Streptococcus, the predominant bacterium to predict the severity of liver injury in alcoholic liver disease", Front. Cell. Infect. Microbiol, 11, pp.649060~ (2021)
  43. Guo M, "Akkermansia muciniphila and Lactobacillus plantarum ameliorate systemic lupus erythematosus by possibly regulating immune response and remodeling gut microbiota", mSphere, 8, pp.e0007023~ (2023)
  44. Dempsey E, "Lactobacillus spp. for gastrointestinal health: current and future perspectives", Front. Immunol, 13, pp.840245~ (2022)
  45. Tsai YS, "Effect of probiotics Lactobacillus paracasei GKS6, L. plantarum GKM3, and L. rhamnosus GKLC1 on alleviating alcohol-induced alcoholic liver disease in a mouse model", Nutr. Res. Pract, 14, pp.299~308 (2020)
  46. Albillos A, "The gut-liver axis in liver disease : pathophysiological basis for therapy", J. Hepatol, 72, pp.558~577 (2020)
  47. Kukuk GM, "Hepatobiliary magnetic resonance imaging in patients with liver disease : correlation of liver enhancement with biochemical liver function tests", Eur. Radiol, 24, pp.2482~2490 (2014)
  48. Bode C, "Activation of the innate immune system and alcoholic liver disease : effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?", Alcohol Clin. Exp. Res, 29, pp.166S~171S (2005)
  49. Setshedi M, "Acetaldehyde adducts in alcoholic liver disease", Oxid Med. Cell Longev, 3, pp.178~185 (2010)
  50. Alvarez CI, "Tumor necrosis factor in neuroplasticity, neurogenesis and alcohol use disorder", Brain Plast, 6, pp.47~66 (2020)
  51. Kawaratani H, "The effect of inflammatory cytokines in alcoholic liver disease", Mediators Inflamm, 2013, pp.495156~ (2013)
  52. Zhang F, "Cyanobacteria blooms and non-alcoholic liver disease : evidence from a county level ecological study in the United States", Environ. Health, 14, pp.41~ (2015)
  53. Guo M, "Akkermansia muciniphila and Lactobacillus plantarum ameliorate systemic lupus erythematosus by possibly regulating immune response and remodeling gut microbiota", mSphere, 8, pp.e0007023~ (2023)
  54. Jun JB, "Klebsiella pneumoniae liver abscess", Infect. Chemother, 50, pp.210~218 (2018)
  55. Gonzlez-Quintela A, "Prevalence of liver disease in patients with Streptococcus bovis bacteraemia", J. Infect, 42, pp.116~119 (2001)

관련 논문AI추천

Effect of probiotics Lactobacillus paracasei GKS6, L. plantarum GKM3, and L. rhamnosus GKLC1 on alleviating alcohol-induced alcoholic liver disease in a mouse modelChen Chin-Chu, Chen Yen-Lien, Lin Shih-Wei, You-Shan Tsai한국영양학회 · Nutrition Research and Practice2020 · 제14권 제4호Microbiota, a key player in alcoholic liver diseaseAnne-Marie Cassard, Dragos Ciocan대한간학회 · Clinical and Molecular Hepatology2018 · 제24권 제2호Oral Administration of Alcohol-Tolerant Lactic Acid Bacteria Alleviates Blood Alcohol Concentration and Ethanol-Induced Liver Damage in RodentsChoi Ga Hee, Choi Hak-Jong, Jang Young Seo, Jo Ha Eun, Jo Hee Eun, Kim Namhee, Mok Ji Ye, Park Hyo Kyeong, Park Sang Min, Seo Jeong Hyun, Yun Misun한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2024 · 제34권 제4호Hepatoprotective Effect of Lactiplantibacillus plantarum DSR330 in Mice with High Fat Diet-Induced Nonalcoholic Fatty Liver Disease백현동, 이나경, Choi Yong-Min, Lee Jinhyeuk, Lee Yunjung, Park Eunju, Ra Jehyeon, Ryu Byung Hee, Shin Da-Soul한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2024 · 제34권 제2호Lactobacillus plantarum and Bifidobacterium longum Alleviate Liver Injury and Fibrosis in Mice by Regulating NF-κB and AMPK SignalingHan Seung-Won, Kim Dong Hyun, Lee Dong-Yun, Shin Jung-Woo, Shin Yoon-Jung한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2024 · 제34권 제1호Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis석기태, 윤기수, 한상학, Byoung Kook Kim, Byung Yong Kim, Do Yup Lee, Haripriya Gupta, Hotaik Sung, Hyeong Seop Kim, Min Jea Shin, Na Young Lee, Sang Jun Yoon, Tae Sik Park, Ye Rin Choi대한간학회 · Clinical and Molecular Hepatology2021 · 제27권 제1호

이 간행물의 다른 논문 (19건)